A high-fat diet can alter intestinal stem cells, promoting tumor development and increasing colon cancer risk. Long-lasting changes in stem cells can make them more responsive to future high-fat exposure, exacerbating the risk.
The ISSCR Consortium brings together industry, academia, and regulatory experts to establish standards and develop tools for stem cell-based models. Takeda's membership aims to accelerate the adoption of human stem cell-derived models in drug discovery and development.
Columbia researchers have developed lab-grown stem-cell models of human placenta formation, allowing for the study of early pregnancy and potential failures. The models mimic the earliest steps of placenta formation, providing a powerful new tool for understanding the development of the critical organ that establishes pregnancy.
Researchers at Anglia Ruskin University have created tiny 'mini lenses' in the lab using human stem cells, resembling natural human lenses. The miniature lenses may help scientists better understand how to prevent or treat cataracts, a condition that affects 94 million people worldwide.
A UCLA-led team developed a manufacturing process for a CRISPR gene-edited stem cell therapy that can be scaled up for clinical trials. The therapy showed promising results in preclinical studies, producing cells with less sickle hemoglobin and stable corrected gene copies.
Researchers at Terasaki Institute are developing 3D-bioprinted retinal grafts using Filamented Light technology to treat age-related macular degeneration and retinitis pigmentosa. The grant will support the development and preclinical validation of this innovative retinal graft platform.
A study discovered that an ancient viral remnant in chimpanzee DNA silences a key gene, LINC00662, which is active in humans and plays a role in early brain development. This finding highlights the importance of understanding gene regulation and its potential link to brain diseases.
The ISSCR 2029 Annual Meeting will take place in Kyoto, Japan, showcasing discoveries across stem cell science and regenerative medicine. The event will foster international collaboration and accelerate progress in the field, with a focus on Japan's scientific leadership.
The ISSCR symposium in Kyoto, Japan celebrates 20 years of iPSC discovery, exploring fundamental discoveries, clinical translation, and emerging stem cell therapies. The event highlights key findings from recent research, including advances in iPSC biology, genetic stability, and disease modeling.
The ISSCR has launched a new CDMO Directory to support stem cell research and clinical translation. The directory connects researchers with contract development and manufacturing organizations, providing a centralized resource for exploring manufacturing capabilities.
Researchers found that nicotine exposure during pregnancy and early childhood can disrupt the development of blood-forming stem cells, leading to a more damaging response to influenza infection in adulthood. This can result in increased inflammation, more severe lung damage, and greater weight loss.
Stem Cell Reports will be the official meeting journal for the Australasian Society for Stem Cell Research 2026 Annual Scientific Meeting. The journal will provide complimentary ISSCR memberships for selected researchers and host a co-branded webinar in 2027.
The International Society for Stem Cell Research (ISSCR) is now accepting abstract submissions and registrations for its 2027 Annual Meeting in San Francisco. The event will showcase groundbreaking discoveries and emerging technologies, including AI advancements and cell-based therapies.
Researchers will study brain activity, cardiovascular function, and accelerated aging in orbit using bioengineered human brain and cardiovascular tissue models. The findings could help identify new ways to protect astronauts' heart health and inform new therapies for cardiovascular disease.
UCLA scientist Tara TeSlaa is developing a new approach to record nutrient use in specific cell types, aiming to build maps of cellular metabolism across tissues and conditions. Her lab will use stable isotope tracing to create a molecular record of nutrient use, allowing for more accurate interpretations of nutrition research.
A study by Chonnam National University explores the therapeutic potential of human dental pulp stem cell secretome in post-stroke functional recovery. The secretome attenuates oxidative stress and inflammation, enhancing recovery in a mouse model, and shows promise for a new therapeutic platform for neurological diseases.
Researchers at the University of Sydney developed a computational framework to evaluate the biological accuracy of lab-grown human embryo models. The study found that while some models perform well, none yet fully capture the complexity of early human development.
Researchers aim to understand the conditions that determine the survival of transplanted retinal cells and develop more effective regenerative therapies for geographic atrophy. They also seek to uncover early mechanisms that contribute to infertility and create a more detailed blueprint for human germ cell development.
Mount Sinai researchers identified how APOE4 damages brain blood vessels, promoting abnormal protein buildup and neurodegeneration. They found that blocking TGF-β signaling restored pericyte coverage, reducing fibrosis and vascular amyloid accumulation.
A UCLA research team engineered immune cells that target atherosclerotic plaques, clearing out rogue smooth muscle cells and inflamed macrophages and foam cells. The 'triple-threat' cells outperformed single-target versions in mouse models and artery tissue, showing promise in treating cardiovascular disease.
The journal welcomes leading researchers with expertise in hematopoietic and muscle stem cell biology, advancing understanding of stem cell research in health and disease. Drs. Bonnet and Relaix bring significant breadth of expertise and commitment to rigorous science, enhancing Stem Cell Reports' impact.
UCLA scientists develop a stem cell-based platform to produce uniform T cells that target solid tumors in a unique way, avoiding a common side effect. The therapy, called AlloESO-T cells, keeps tumors in check and extends survival in mouse models of ovarian, melanoma, and prostate cancers.
Researchers at Boston Medical Center and Boston University have developed a scalable method for generating CD4+ helper T cells from induced pluripotent stem cells (iPSCs), overcoming a longstanding challenge in the development of stem cell-based immunotherapies. This breakthrough could help advance efforts to create off-the-shelf CAR-T...
Dr. Georg Aue, a nationally recognized blood cancer expert, has been named the inaugural director of the Stem Cell Transplant and Cellular Therapy Program at UT Health San Antonio. The program aims to increase access to new therapeutic approaches for patients across South Texas, with a focus on clinical excellence, research innovation,...
The DKMS John Hansen Research Grant supports innovative cell therapy approaches and transplant immunology. The grant enables young researchers to build a network and advance lifesaving therapies for blood cancer.
Dr. Lorenz Studer is known for his pioneering advances in stem cell biology, regenerative medicine, and the development of stem cell-based therapies for neurodegenerative disease.
The Marcus Foundation has awarded $28.7 million to advance a clinical trial testing a stem cell-based therapy designed to regenerate damaged heart tissue after a heart attack. Researchers aim to develop approaches that could reduce or eliminate the need for immunosuppressive drugs.
A new study investigates the efficacy of stem cell injections for treating knee osteoarthritis, finding that MSC potency can be predicted through lab-based tests. Patients who showed improved pain and mobility scores had MSCs with enhanced anti-inflammatory effects.
A new study found that children preparing for stem cell transplantation already have subtle respiratory abnormalities, including increased small-airway resistance and greater lung stiffness. These abnormalities are likely related to their underlying disease or previous therapies rather than the transplant itself.
Scientists have discovered that TRF2, a protein previously known for protecting chromosome ends, plays a crucial role in preserving the identity of muscle stem cells and enabling their regenerative abilities. This new understanding may lead to the development of therapeutic strategies for muscular dystrophy and cancer research.
The Alliance QUANTUM trial is testing whether post-transplant consolidation therapy with teclistamab improves survival in patients with primary plasma cell leukemia. Plasma cell leukemia is a rare but aggressive blood cancer with poor long-term survival rates.
The International Society for Stem Cell Research (ISSCR) has recognized five outstanding researchers for their innovative work on developmental biology, disease modeling, regenerative medicine, and functional genomics. The award winners were selected from over 1,300 scientific posters presented at the ISSCR 2026 Annual Meeting in Montr...
Researchers evaluate whether hypoimmune cell engineering can help transplanted insulin-producing cells survive without chronic immunosuppression. The study aims to develop a cell replacement approach that can function without chronic immunosuppression, providing a curative therapy for people with type 1 diabetes.
The STEM-PD trial demonstrated the safety and feasibility of stem cell-derived dopaminergic cell transplantation in patients with moderate to advanced Parkinson's disease. The findings mark an important step in evaluating this approach as a potential treatment strategy for neurodegenerative diseases.
Researchers at ISSCR 2026 present interim clinical findings from the first Phase 1/2a trial of autologous iPSC-derived dopamine neuron precursor cells for Parkinson's disease. The approach uses each patient's own cells, and new genomic quality control methods ensure the manufactured cells are suitable for transplantation.
Early signs of clinical improvement have been observed in patients with treatment-resistant systemic sclerosis treated with investigational stem cell-derived CAR T-cell therapy, known as FT819. The therapy has demonstrated a reassuring safety profile and has the potential to expand access to patients who might otherwise face barriers t...
The REGEN4HD study marks a significant milestone in the development of regenerative medicine approaches for Huntington's disease. The Phase 1b/2a trial enrolls early-stage symptomatic patients to evaluate safety and tolerability.
A Phase 1/2a clinical study demonstrates long-term survival of transplanted human neural progenitor cells in patients with retinitis pigmentosa, maintaining a favorable safety profile. Visual acuity remained stable, and imaging showed cells remaining present in the subretinal space for at least one year.
Researchers present new insights into an iPSC-derived neural progenitor cell therapy for chronic ischemic stroke, demonstrating safety and biological activity over extended follow-up. The findings have the potential to expand treatment options for patients living with chronic stroke disability.
The International Society for Stem Cell Research convenes its 2026 Annual Meeting in Montréal, showcasing groundbreaking discoveries and emerging clinical advances. The meeting features nearly 1,300 scientific posters and presentations spanning every area of stem cell research.
Encellin reports non-fibrotic engraftment and host vascularization in Phase 1 trial participants, building on interim results. The findings support the company's approach to deliver cell therapy safely and durably without immunosuppression.
Researchers have developed vascular organoid patches that can regenerate microvessels in the heart, leading to improved heart function and reduced progression of coronary artery disease. The patches were shown to survive for several weeks and stimulate new microvessel formation, providing a potential treatment for ischemic heart disease.
A recent study published in Stem Cell Reports found that prenatal high fructose exposure impairs fetal brain stem cell function, leading to long-lasting effects on learning and memory. The researchers discovered distinct epigenetic changes in fetal neural stem cells that persisted into adulthood, affecting gene expression and adult neu...
The project aims to systematically map how individual pairs of cells influence each other, with the goal of understanding cell-cell communication in health and disease. By characterizing the cellular dyad, scientists can determine which cell influenced which partner, when the interaction began and what changed as a result.
Researchers found cytoskeletal proteins in cell nuclei of neural stem cells, influencing developmental programs. MAP1B protein helps maintain stem cell state for longer, contributing to abnormal brain development.
The International Society for Stem Cell Research announces the launch of a global consortium focused on integrating human stem cell-derived models into preclinical drug development. Bayer is a founding member, aiming to establish standardized frameworks and regulatory guidance for these models.
Researchers successfully generated rat-derived kidneys in mice using interspecies blastocyst complementation, demonstrating potential for growing transplantable human organs in larger animals. The study represents an important step toward addressing global kidney shortages.
Researchers at Stanford University found that electrical pulses can significantly extend the lifespan of sea squirts by rejuvenating their stem cells. The treatment causes a "reboot and rebound" of gene activity, similar to effects observed in humans after stress and exercise, leading to improved health and longevity.
Researchers have discovered a link between tooth aging and the decline of dental pulp stem cells' regenerative capacity. A unique subset of DPSCs, expressing NFATC1 protein, is essential for tooth regeneration. Eliminating this subset can lead to senescence and reduced ability to regenerate after injury.
The ISSCR Consortium supports the FDA's draft guidance on using new approach methodologies (NAMs) in drug development, emphasizing the need for a flexible and science-driven framework. The consortium recommends clarifying biological complexity alignment with context of use and expanding recognition of computational modeling and hybrid ...
Researchers developed cardiac organoids to address limitations of cell-based therapies in myocardial infarction. These three-dimensional tissue constructs integrate into host tissue, improve cardiac function, and reduce scar size without arrhythmogenic effects.
ISSCR 2027 will bring together scientists, industry leaders, and students to discuss breakthroughs in development, regeneration, AI, and bioengineering. The meeting emphasizes scientific exchange and career development through networking events and mentoring opportunities.
A recent study by Dr. Walaa Oweis and Prof. Eran Meshorer found that protein clumps in the brain may actually be protecting neurons from stress, acting as a vital quarantine system.
Researchers discovered that early-stage ectoderm cells are especially susceptible to SARS-CoV-2 infection, with heightened vulnerability driven by elevated TMPRSS2 activity and thinner glycocalyx. This raises concerns about potential developmental risks, particularly for infants born to mothers infected during early pregnancy.
The ISSCR emphasizes that continued investment in hESC research is essential to sustaining scientific progress and advancing life-saving therapies. Human embryonic stem cells remain a cornerstone of modern biomedical research due to their status as a gold standard for human pluripotency.
Scientists at Karolinska Institutet have created a new method to produce insulin-producing cells from human stem cells, effectively regulating blood sugar levels in laboratory tests and reversing diabetes in mice. The optimized production process yields more mature and purer cells, demonstrating their potential for future treatments.
A new study uses a human stem cell-derived model to identify potential therapies for inflammatory bowel disease (IBD), highlighting glycyrrhizin as a promising candidate. Glycyrrhizin significantly prevents intestinal cell death in both stem cell models and mice with IBD, reducing inflammation and cell death.
The Stem Cell Report podcast has marked five years of exploration in stem cell research, capturing significant progress in human development, disease, and regenerative medicine. The anniversary episode reunites past guests to discuss the field's evolution, highlighting advances in therapies, organoid systems, and global standards.
The ISSCR has elected Malin Parmar as vice president, bringing expertise in cellular neuroscience and regenerative therapies. The newly elected Board of Directors includes experts in engineering, biology, medicine, biomedical ethics, and public policy, who will guide the Society's global mission to advance excellence in stem cell science.
STEM Cell Reports has been named the official journal of the 2026 BaCell 3D Organoid Conference in Basel, Switzerland. The conference will bring together leading scientists and experts to share their latest findings on organoid technologies and disease modeling.